What this guide is, and is not
Tirzepatide reduces how much you want to eat, and the FDA-approved label says it is to be used with a reduced calorie diet. That combination raises a fair question: with less appetite and fewer calories, what should the food that does get eaten look like, and does a plant based way of eating fit? This guide answers from three kinds of source, the Zepbound® label, the federal Dietary Guidelines for Americans, and peer reviewed reviews found through PubMed, and it reports only what those sources support. It is not a meal plan, and it is not medical or dietary advice. What you should eat on treatment is a question for your licensed provider or a dietitian they refer you to.
The label describes Zepbound®, the branded product. Personalized Compounded tirzepatide, which Bodi Envi’s programs may include, is not FDA-approved and is not equivalent to Zepbound®.
Personalized compounded medications differ from commercially available brand-name products in formulation, concentration, excipients, preparation methods, and other characteristics. Accordingly, clinical data from studies involving brand-name products should not be assumed to apply to personalized compounded formulations.
At this time, the studies referenced above have not evaluated the specific personalized compounded formulations being provided. Therefore, no claims of equivalence in safety, efficacy, quality, or clinical outcomes should be inferred from these studies.
What the label says about food
The Zepbound® prescribing information says the medication is indicated in combination with a reduced calorie diet and increased physical activity, and its clinical studies section describes what that meant in the trials: instruction on a reduced calorie diet with a deficit of approximately 500 calories a day, and counselling on increased physical activity with a recommended minimum of 150 minutes a week, beginning with the first dose and continuing throughout. The label gives no meal plan, no list of foods and no macronutrient targets. It does not mention vegan, vegetarian or any other dietary pattern.
Two other statements in the label bear on eating. It says tirzepatide delays gastric emptying, which is the mechanism behind nausea, fullness, reflux and belching, and the reason it can affect the absorption of oral medications. And its medication guide says that diarrhea, nausea and vomiting may cause dehydration that can lead to kidney problems, and that it is important to drink fluids. Both point the same way: smaller amounts, eaten more deliberately, with fluids that do not depend on appetite.
Personalized compounded medications differ from commercially available brand-name products in formulation, concentration, excipients, preparation methods, and other characteristics. Accordingly, clinical data from studies involving brand-name products should not be assumed to apply to personalized compounded formulations.
At this time, the studies referenced above have not evaluated the specific personalized compounded formulations being provided. Therefore, no claims of equivalence in safety, efficacy, quality, or clinical outcomes should be inferred from these studies.
What the Dietary Guidelines say
The Dietary Guidelines for Americans are issued every five years by the U.S. Departments of Health and Human Services and Agriculture, and the Office of Disease Prevention and Health Promotion describes them as advice on nutrition intake to meet nutrient needs, promote health and prevent disease. The 2025 to 2030 edition is published at RealFood.gov. Its headline advice is to build diets on whole, nutrient dense foods, which it lists as protein, dairy, vegetables, fruits, healthy fats and whole grains, and, for the first time in an official edition, to avoid highly processed food, which it describes as packaged, prepared or ready to eat foods that are salty or sweet with added sugars and salt.
On protein, the guidelines say every meal should prioritize high quality, nutrient dense protein from both animal and plant sources, paired with healthy fats from whole foods, and they give a target of 1.2 to 1.6 grams of protein per kilogram of body weight per day. They encourage a wide variety of whole vegetables and fruits in their original form, prioritize fiber-rich whole grains, and say refined carbohydrates should be significantly reduced.
None of that is written for people on tirzepatide, and this guide does not claim the target applies to treatment unchanged. It is reported because it is the current federal statement of what a good diet contains, and because its emphasis on protein and whole foods matches what the reviews below say matters most during weight loss on these medications.
What the reviews say about eating on treatment
A 2026 narrative review by Fujioka in Nutrition in Clinical Practice, found through PubMed, reports that GLP-1 receptor agonists significantly reduce meal size, may decrease water intake, affect the choice of highly palatable foods, and that the gastrointestinal side effects most patients experience can often be managed with dietary adjustments. It reports that loss of lean tissue, including bone and muscle, has been reported, that vitamin deficiencies have been reported, and concludes that nutritional counselling becomes invaluable.
A 2026 review by Nobakht and colleagues in Cardiorenal Medicine reports that weight loss on incretin-based therapies is typically fat-predominant, but that available studies suggest approximately 25 to 39 percent of total weight loss may reflect lean body mass over 36 to 72 weeks, and it names resistance training and nutrition optimization among early mitigation strategies.
Put beside the Dietary Guidelines, those reviews explain why protein is the thread through this topic. Less food is eaten, some of the weight lost is muscle, and the published responses are protein, resistance work and attention to nutrients. What that means in grams for you is not something this guide can say.
Plant based eating, per the reviews
The label is silent on plant-based diets, so this section relies on two peer reviewed reviews. A 2026 critical narrative review by Clemente-Suárez and colleagues in Nutrients compares vegan, vegetarian and omnivorous patterns and argues that the dominant factor in long term outcomes is dietary pattern quality, a minimally processed plant-rich composition, nutrient adequacy, low intake of ultra-processed food and adherence, rather than whether animal foods are included at all. It describes well planned vegan and vegetarian patterns as valid dietary expressions that require systematic attention to vitamin B12, iodine, iron, zinc, calcium, vitamin D, the omega-3 fats EPA and DHA, and protein quality.
A 2025 narrative review by Jakše and colleagues in Food and Function evaluated sixteen interventional studies of vegan diets and adult body composition. According to its abstract, vegan diets led to greater reductions in body weight and more favorable body composition changes than various control diets in those studies, but some studies reported significant muscle mass loss, and the strategies used to mitigate it were regular physical activity, particularly resistance training, sufficient protein intake, and modest energy restriction without compromising nutrient adequacy. The review notes that achieving nutritional adequacy on a vegan diet requires careful planning, as with any well-designed diet.
Neither review studied people taking tirzepatide, and this guide makes no claim about combining the two. What the reviews establish is that a plant-based pattern is a recognized way of eating with specific nutrients to plan for, and that the same two concerns the incretin reviews raise, protein and muscle, are the ones the vegan diet literature raises too. For someone on tirzepatide who eats plant based, that overlap is the reason to involve a provider or dietitian rather than a reason to stop.
What the sources support doing
Kept to what the label, the guidelines and the reviews support, the list is short. Drink fluids, which the label asks for directly. Eat regularly in smaller amounts, which follows from the reviews’ description of reduced meal size and the label’s account of delayed gastric emptying. Build meals on whole, nutrient dense foods and limit highly processed ones, which is the Dietary Guidelines’ central advice. Prioritize protein at each meal, from animal or plant sources, which the guidelines state and the incretin reviews give a reason for. Include resistance training in the increased physical activity the label calls for, which both the incretin and the vegan reviews name as the response to muscle loss. If you eat plant based, plan for the nutrients the Nutrients review lists, and raise supplementation with your provider rather than deciding alone. And tell your provider how you are eating, because the Fujioka review’s conclusion is that counselling is the tool, and counselling needs the facts.
What the care team messaging is for
Bodi Envi’s programs include messaging with your care team through the patient portal, and questions about eating on treatment belong there: how much you are managing to eat, whether nausea is shaping your meals, whether you follow a plant-based pattern, and what supplements you take. A licensed provider, through Wasef Health, PC for applicable programs, makes the clinical decisions and can refer you for dietary advice if appropriate. Bodi Envi is a LegitScript-certified U.S. telehealth platform and not a medical practice, pharmacy or medication manufacturer, and it does not provide dietary plans.
Personalized Compounded tirzepatide is not FDA-approved and is not equivalent to Zepbound®; the label and reviews cited describe the branded products and general diets, not compounded treatment. This guide is general information and not medical or dietary advice, and your provider is the person to ask.